Basic Information
| LncRNA/CircRNA Name | lncRNA-CTBP |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | HCC tissues |
| Expression Pattern | up-regulated |
| Function Description | We examined RNA-based biomarker panel expression level in 20 paired HCC tissues and adjacent non-tumor tissues by qRT-PCR. In tumor tissues, lncRNA-CTBP, miR-16-2, miR-21-5p expression were at a level higher than that of non-tumor tissues, with the median ratio of 421, 0.26; 12.7, 0.24; and 13.02, 0.28, respectively, compared with normal counterparts. |
| Pubmed ID | 27113935 |
| Year | 2016 |
| Title | Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma. |
External Links
| Links for lncRNA-CTBP | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |